Cerebrospinal fluid β2-microglobulin, monocyte chemotactic protein-1, and soluble tumour necrosis factor α receptors before and after treatment with lamivudine plus zidovudine or stavudine
2000 ◽
Vol 102
(2)
◽
pp. 216-221
◽
2007 ◽
Vol 31
(5)
◽
pp. 565-573
◽
1996 ◽
Vol 66
(1-2)
◽
pp. 115-123
◽
1996 ◽
Vol 12
(5)
◽
pp. 617-634
◽
2009 ◽
Vol 30
(7)
◽
pp. 977-978
◽
1997 ◽
Vol 19
(3)
◽
pp. 197-201
◽